3653 results for «439»
3653 results
Featured cases - Strategic approaches in mitral regurgitation
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in this featured session showcasing strategic approaches in the management of mitral regurgitation. Explore a range of complex cases, including percutaneous annuloplasty with a novel device in functional mitral regurgitation, the management of mitral annulus cavity and regurgitation post-healed endocarditis, simultaneous management of two...
Featured research - Tricuspid valve (Part 2)
24 Nov 2024 – From PCR London Valves 2024
Delve into the latest research on tricuspid valve interventions in this second featured session from PCR London Valves 2024. Gain insights into the characteristics and outcomes of severe isolated tricuspid regurgitation across different treatment strategies, the issue of valve thrombosis after TTVR, the one-year robustness of...
Featured research - Aortic valve (Part 2)
24 Nov 2024 – From PCR London Valves 2024
This second part of the featured research session on aortic valve interventions delves into a wide range of topics, including vascular complications, valve-in-valve TAVI, coronary protection strategies, predictors of mortality, and innovative techniques. Discover the latest advancements and insights from cutting-edge research.
Featured cases - TAVI in bicuspid valve anatomy (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Explore a unique collection of featured TAVI cases in bicuspid valve anatomy. Witness the successful navigation of complex scenarios, including the treatment of severely calcified bicuspid valves, handling of extreme annular dimensions, and the utilization of specialized techniques like antegrade transseptal TAVI. Gain insights that can...
Featured cases - TAVI in SAVR (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Delve into a collection of compelling TAVI cases involving prior surgical aortic valve replacement (SAVR). Witness the nuances of valve-in-valve TAVI, including the importance of pre-dilation and the challenges of uncrossable valves. Gain insights into managing severe aortic regurgitation in failed bio-Bentall procedures and navigating TAVI...
Featured cases - Complications of mitral TEER
24 Nov 2024 – From PCR London Valves 2024
Delve into a series of compelling cases highlighting complications associated with mitral transcatheter edge-to-edge repair (TEER) procedures. Witness the management of leaflet perforation, single leaflet detachment, and left atrial perforation. Explore innovative bailout strategies and the challenges posed by M-TEER. This session offers valuable lessons to...
Rapid-Fire - Rare and unusual (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in a captivating collection of rare and unusual interventional cardiology cases. Witness the first known case of dual valve-in-valve replacement in caval valve implantation, the management of device-related allergic reactions, and the treatment of left atrial thrombi associated with appendage occlusion devices. Explore solutions...
How to establish a mitral TEER programme
24 Nov 2024 – From PCR London Valves 2024
Ready to start your journey toward establishing a mitral TEER programme? This video covers everything you need to know—from understanding the contemporary role of TEER in managing mitral regurgitation to building a Heart Team and referral network.
Learn how to find your first cases, select the right...
EuroPCR 2026 – Coronary revascularisation in patients undergoing TAVI
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is an individual participant data meta-analysis of 4 randomised controlled trials...
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES
30 Aug 2023
Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.
Author
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons
23 Jan 2025
Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.
Author
Author
